Optineurin and its mutants: Molecules associated with some forms of glaucoma

Ophthalmic Research

Volumn 42, Issue 4, 2009, Pages 176-184

  Chalasani, Madhavi Latha ^a   Swarup, Ghanshyam ^b   Balasubramanian, Dorairajan ^a  

^a L V PRASAD EYE INSTITUTE   (India)

^b CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Apoptosis; Normal tension glaucoma; Optineurin; Oxidative stress; Primary open angle glaucoma; Vesicular trafficking

Indexed keywords

COMPLEMENTARY DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUTANT PROTEIN; OPTINEURIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; CELLULAR DISTRIBUTION; GENE MUTATION; GLAUCOMA; HUMAN; HUMAN CELL; NONHUMAN; OPEN ANGLE GLAUCOMA; OXIDATIVE STRESS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; REVIEW;

ANIMALS; APOPTOSIS; CERCOPITHECUS AETHIOPS; GLAUCOMA, OPEN-ANGLE; HUMANS; LOW TENSION GLAUCOMA; MUTANT PROTEINS; OXIDATIVE STRESS; PROTEIN BINDING; RATS; RETINAL GANGLION CELLS; TRANSCRIPTION FACTOR TFIIIA;

EID: 68349104931     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000232400     Document Type: Review

References (39)

1. Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados M, Héon E, Krupin T, Ritch R, Kreutzer D, Crick RP, Sarfarazi M: Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002; 295: 1077-1079.
2. Aung T, Ocaka L, Ebenezer ND, Morris AG, Brice G, Child AH, Hitchings RF, Lehmann OJ, Bhattacharya SS: Investigating the association between OPA1 polymorphism and glaucoma: comparison between normal tension and high tension primary open angle glaucoma. Hum Genet 2002; 110: 513-514.
3. Mabuchi F, Tang S, Keshiwagi K, Yamagata Z, Iijima H, Tsukahara S: The OPA1 gene polymorphism is associated with normal tension and high tension glaucoma. Am J Ophthalmol 2007; 143: 125-130.
4. Schwamborn K, Weil R, Courtois G, Whiteside ST, Israël A: Phorbol esters and cytokines regulate the expression of the NEMOrelated protein, a molecule involved in a NF-kappa B-independent pathway. J Biol Chem 2000; 275: 22780-22789.
5. Park BC, Shen X, Samaraweera M, Yue BY: Studies of optineurin, a glaucoma gene: Golgi fragmentation and cell death from overexpression of wild-type and mutant optineurin in two ocular cell types. Am J Pathol 2006; 169: 1976-1989.
6. Li Y, Kang J, Horwitz MS: Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains. Mol Cell Biol 1998; 18: 1601-1610.
7. Alward WL, Kwon YH, Kawase K, Craig JE, Hayreh SS, Johnson AT, Khanna CL, Yamamoto T, Mackey DA, Roos BR, Affatigato LM, Sheffield VC, Stone EM: Evaluation of optineurin sequence variations in 1,048 patients with open-angle glaucoma. Am J Ophthalmol 2003; 136: 904-910.
8. Aung T, Rezaie T, Okada K, Viswanathan AC, Child AH, Brice G, Bhattacharya SS, Lehmann OJ, Sarfarazi M, Hitchings RA: Clinical features and course of patients with glaucoma with the E50K mutation in the optineurin gene. Invest Ophthalmol Vis Sci 2005; 46: 2816-2822.
9. Willoughby CE, Chan LL, Herd S, Billingsley G, Noordeh N, Levin AV, Buys Y, Trope G, Sarfarazi M, Héon E: Defining the pathogenicity of optineurin in juvenile open-angle glaucoma. Invest Ophthalmol Vis Sci 2004; 45: 3122-3130.
10. Mukhopadhyay A, Komatireddy S, Acharya M, Bhattacharjee A, Mandal AK, Thakur SK, Chandrasekhar G, Banarjee A, Thomas R, Chakrabarti S, Ray K: Evaluation of optineurin as a candidate gene in Indian patients with primary open angle glaucoma. Mol Vis 2005; 11: 792-797.
11. Sripriya S, Nirmaladevi J, George R, Hemamalini A, Baskaran M, Prema R, Ve Ramesh S, Karthiyayini T, Amali J, Job S, Vijaya L, Kumaramanickavel G: OPTN gene: Profile of patients with glaucoma from India. Mol Vis 2006; 12: 816-820.
12. Kumar A, Basavaraj MG, Gupta SK, Qamar I, Ali AM, Bajaj V, Ramesh TK, Prakash DR, Shetty JS, Dorairaj SK: Role of CYP1B1, MYOC, OPTN and OPTC genes in adult-onset primary open-angle glaucoma: Predominance of CYP1B1 mutations in Indian patients. Mol Vis 2007; 13: 667-676.
13. Yuan HP, Xiao Z, Xu N, Yang BB, Meng QF, Li YY: Study of novel mutation of OPTN gene in two primary open angle glaucoma families in northeast China. Zhonghua Yan Ke Za Zhi 2008; 44: 147-151.
14. Liu U, Akafo S, Santiago-Turla C, Cohen C, Larocque-Abramson KR, Qin X, Herndon LW, Challa P, Schmidt S, Hauser MA, Allingham RR: Optineurin coding variants in Ghanaian patients with primary open-angle glaucoma. Mol Vis 2008; 14: 2367-2372.
15. Baird PN, Richardson AJ, Craig JE, Mackey DA, Rochtchina E, Mitchell P: Analysis of optineurin (OPTN) gene mutations in subjects with and without glaucoma: the Blue Mountains Eye Study. Clin Experiment Ophthalmol 2004; 32: 518-522.
16. Craig JE, Hewitt AW, Dimasi DP, Howell N, Toomes C, Cohn AC, Mackey DA: The role of the Met98Lys optineurin variant in inherited optic nerve diseases. Br J Ophthalmol 2006; 90: 1420-1424.
17. Hattula K, Peranen J: FIP-2, a coiled-coil protein, links Huntingtin to Rab8 and modulates cellular morphogenesis. Curr Biol 2000; 10: 1603-1606.
18. Sahlender DA, Roberts RC, Arden SD, Spudich G, Taylor MJ, Luzio JP, Kendrick-Jones J, Buss F: Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis. J Cell Biol 2005; 169: 285-295.
19. Moreland RJ, Dresser ME, Rodgers JS, Roe BA, Conaway JW, Conaway RC, Hanas JS: Identification of a transcription factor IIIAinteracting protein. Nucleic Acids Res 2000; 28: 1986-1993.
20. Anborgh PH, Godin C, Pampillo M, Dhami GK, Dale LB, Cregan SP, Truant R, Ferguson SS: Inhibition of metabotropic glutamate receptor signaling by the huntingtin-binding protein optineurin. J Biol Chem 2005; 280: 34840-34848.
21. Zhu G, Wu CJ, Zhao Y, Ashwell JD: Optineurin negatively regulates TNFalpha-induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP. Curr Biol 2007; 17: 1438-1443.
22. Vittitow J, Borrás T: Expression of optineurin, a glaucoma-linked gene, is influenced by elevated intraocular pressure. Biochem Biophys Res Commun 2002; 298: 67-74.
23. Kamphuis W, Schneemann A: Optineurin gene expression level in human trabecular meshwork does not change in response to pressure elevation. Ophthalmic Res 2003; 35: 93-96.
24. Yuan L, Neufeld AH: Tumor necrosis factorα : A potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 2000; 32: 42-50.
25. Tezel G, Wax MB: Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci 2000; 20: 8693-8700.
26. Tezel G, Wax MB: The mechanisms of hsp27 antibody-mediated apoptosis in retinal neuronal cells. J Neurosci 2000; 20: 3552-3562.
27. Cotinet A, Goureau O, Hicks D, Thillaye- Goldenberg B, De Kozak Y: Tumor necrosis factor and nitric oxide production by retinal Müller glial cells from rats exhibiting inherited retinal dystrophy. Glia 1997; 20: 59-69. (Pubitemid 27207008)
28. Funayama T, Ishikawa K, Ohtake Y, Tanino T, Kurosaka D, Kimura I, Suzuki K, Ideta H, Nakamoto K, Yasuda N, Fujimaki T, Murakami A, Asaoka R, Hotta Y, Tanihara H, Kanamoto T, Mishima H, Fukuchi T, Abe H, Iwata T, Shimada N, Kudoh J, Shimizu N, Mashima Y: Variants in optineurin gene and their association with tumor necrosis factorα polymorphisms in Japanese patients with glaucoma. Invest Ophthalmol Vis Sci 2004; 45: 4359-4367.
29. Park BC, Tibudan M, Samaraweera M, Shen X, Yue BY: Interaction between two glaucoma genes, optineurin and myocilin. Genes Cells 2007; 12: 969-979.
30. Chalasani ML, Radha V, Gupta V, Agarwal N, Balasubramanian D, Swarup G: A glaucoma- associated mutant of optineurin selectively induces death of retinal ganglion cells which is inhibited by antioxidants. Invest Ophthalmol Vis Sci 2007; 48: 1607-1614.
31. De Marco N, Buon M, Troise F, Diez-Roux G: Optineurin increases cell survival and translocates to the nucleus in a RAB8 dependent manner upon an apoptotic stimulus. J Biol Chem 2006; 281: 16147-16156.
32. Chalasani ML, Balasubramanian D, Swarup G: Focus on molecules: optineurin. Exp Eye Res 2008; 87: 1-2.
33. Wiggs JL, Allingham RR, Hossain A, Kern J, Auguste J, DelBono EA, Broomer B, Graham FL, Hauser M, Pericak-Vance M, Haines JL: Genome-wide scan for adult onset primary open angle glaucoma. Hum Mol Genet 2000; 9: 1109-1117.
34. Assier E, Bouzinba-Segard H, Stolzenberg MC, Stephens R, Bardos J, Freemont P, Charron D, Trowsdale J, Rich T: Isolation, sequencing and expression of RED, a novel human gene encoding an acidic-basic dipeptide repeat. Gene 1999; 230: 145-154.
35. Aung T, Ebenezer ND, Brice G, Child AH, Prescott Q, Lehmann OJ, Hitchings RA, Bhattacharya SS: Prevalence of optineurin sequence variants in adult primary open angle glaucoma: implications for diagnostic testing. J Med Genet 2003; 40:e101.
36. Hauser MA, Sena DF, Flor J, Walter J, Auguste J, Larocque-Abramson K, Graham F, Delbono E, Haines JL, Pericak-Vance MA, Rand Allingham R, Wiggs JL: Distribution of optineurin sequence variations in an ethnically diverse population of low-tension glaucoma patients from the United States. J Glaucoma 2006; 15: 358-363.
37. Ayala-Lugo RM, Pawar H, Reed DM, Lichter PR, Moroi SE, Page M, Eadie J, Azocar V, Maul E, Ntim-Amponsah C, Bromley W, Obeng-Nyarkoh E, Johnson AT, Kijek TG, Downs CA, Johnson JM, Perez-Grossmann RA, Guevara-Fujita ML, Fujita R, Wallace MR, Richards JE: Variation in optineurin (OPTN) allele frequencies between and within populations. Mol Vis 2007; 13: 151-163.
38. Fuse N, Takahashi K, Akiyama H, Nakazawa T, Seimiya M, Kuwahara S, Tamai M: Molecular genetic analysis of optineurin gene for primary open-angle and normal tension glaucoma in the Japanese population. J Glaucoma 2004; 13: 299-303.
39. Weisschuh N, Neumann D, Wolf C, Wissinger B, Gramer E: Prevalence of myocilin and optineurin sequence variants in German normal tension glaucoma patients. Mol Vis 2005; 11: 284-287.